VIVA Physicians Media Kit
VIVA Physicians Boilerplate
VIVA Physicians is a not-for-profit organization dedicated to advancing the field of vascular medicine and
intervention through education and research. VIVA's mission is demonstrated through activities such as
supporting a multidisciplinary fellowship, collaborating with International vascular symposia, interacting
with policy makers, supporting and contributing to philanthropy. Since 2003, VIVA Physicians has
sponsored an annual symposium in Las Vegas, Nevada where recognized experts from around the world
come to share the latest research, learn about innovative technologies and therapies for vascular
disease, and discuss the latest efforts to improve vascular patient care. To learn more about
VIVA Physicians visit www.vivaphysicians.org . You can also connect with VIVA Physicians on Facebook,
Twitter and LinkedIn.
About VIVA Physicians

Founded in 2003, Vascular InterVentional Advances (VIVA) is a not-for-profit physician
organization dedicated to advancing the field of vascular medicine and intervention through
education and research.

The VIVA Board is comprised of 15 physicians who treat patients with vascular disease and
represent an array of specialties including vascular medicine, vascular surgery, interventional
radiology and cardiology.

Throughout the year, VIVA’s mission is supported through activities such as funding a
multidisciplinary fellowship, collaborating with worldwide vascular meetings, interacting with
policy makers, supporting and participating in vascular research, development of awareness
initiatives and philanthropy.

As vascular care evolves, VIVA aims to provide educational opportunities that will allow
attendees to stay on top of the field, engage with new colleagues, learn from other specialists,
and glimpse into the future of vascular care.
About VIVA 14

In 2003, VIVA Physicians began holding an annual multidisciplinary vascular education
conference in Las Vegas, NV. Each year, recognized experts and attendees from around the
world come to learn innovative technologies and therapies for vascular disease to improve
vascular patient care.

At VIVA 14, there are multiple learning venues, where attendees can pick the format that works
best for their individual style. New programs are developed each year based on feedback and
findings from the previous year.

VIVA 14 offers a world-renowned faculty comprised of all specialties devoted to the treatment
of patients with vascular diseases combined with groundbreaking educational technology.
Handpicked as the most passionate educators, the faculty dedicate themselves to evidencebased care.

VIVA 14 also provides participants with personalized educational tools, including Virtual VIVA,
live cases with robust multidisciplinary discussion, and many venues for interaction between
faculty and attendees.

Virtual VIVA is a new learning tool offering attendees the ability to watch live-streaming of
various sessions and live cases, interact with faculty through Q&A, reference presentations, and
access resources from their own device.

For the first time, VIVA has teamed up with VitalMedical to integrate Google Glass into the Cath
Lab and stream live cases.

Attendees at VIVA 14 include physicians, technologists, industry members, physician assistants,
nurse practitioners, and nurses who specialize in interventional cardiology, interventional
radiology, vascular medicine, vascular surgery, cardiothoracic surgery, neurosurgery and
neuroradiology.

VIVA also offers a two-day session designed specifically for cardiovascular healthcare
professionals (including nurses, vascular clinic staff, endovascular operating room staff,
interventional suite staff, nurse practitioners, vascular technologists and physician assistants)
who are interested in the management of patients with vascular disease.

For the fourth year in a row, VIVA Physicians is collaborating with the Society for Vascular
Medicine (SVM) to offer The Comprehensive Review Course on Vascular and Endovascular
Medicine (CRC) prior to the start of VIVA 13.

New to VIVA this year is VIVA 365, a social media lounge that will teach attendees the basics of
social media and how to engage with VIVA all year long. The lounge will also offer a
complimentary Wi-Fi hotspot to connect to the outside world on any mobile device.
About VIVA 365



Launched in November of 2014, www.VIVA365.org is VIVA’s new educational news platform
offering rich educational content all year round.
Has secured over 50 unique contributors from an array of specialties with vascular expertise.
Includes articles from unique perspectives, challenging quizzes, interactive cases, short news
videos, etc.
VIVA Physicians’ Board Member
Gary M. Ansel , MD Interventional Cardiology
Dr. Gary Ansel is an internationally renowned interventional expert in both
peripheral vascular and Cardiovascular procedures. He is Associate Medical Director
of the OhioHealth Research and Innovation Institute and serves on the OhioHeath
Research Industry Council. He has recently been named as System Medical Chief Vascular Program at OhioHealth in Columbus, OH.
Joshua A. Beckman, MD Vascular Medicine
Dr. Joshua Beckman is Associate Professor of Medicine at Harvard Medical School
and Vascular Medicine Section in the Cardiovascular Division at Brigham and
Women's Hospital, both in Boston. He is the Past President of the Society of
Vascular Medicine and is active in numerous other professional organizations,
including the ACC and AHA. He has won the ACC's W. Proctor Harvey Young Teacher
Award.
Michael D. Dake, MD Interventional Radiology
Dr. Michael Dake is Professor of Cardiothoracic Surgery at Stanford University School of Medicine and
Medical Director of the Catheterization and Angiography Laboratories at Stanford University Medical
Center. Previously, he served as Division Chief of Interventional Radiology for 15 years at Stanford
before being named Chairman of the Department of Radiology at the University of Virginia. He returned
to Stanford in 2008 where he focuses on developing endovascular procedures to manage patients with
thoracic and abdominal diseases. In addition, his research interests include the use of drug-eluting
stents and balloons for the treatment of peripheral arterial disease and the use of percutaneous
therapies to address a range of venous lesions. In addition to specialty certification in Diagnostic
Radiology and Vascular and Interventional Radiology, Dr. Dake is board certified in Internal Medicine
and Pulmonary Disease.
Tony S. Das, MD Interventional Cardiology
Dr. Das is a founding member of VIVA. He is a board-certified peripheral
interventional cardiologist with national expertise in (CTO) recanalization and new
device testing and development. Dr. Das is the chief of Cardiology and
Interventional Endovascular Department at the Walnut Hill Medical Center.
Michael R. Jaff, DO Vascular Medicine
Michael R. Jaff, DO is Associate Professor of Medicine at Harvard Medical School,
Chair of the MGH Institute for Heart, Vascular, and Stroke Care, Medical Director of
the Vascular Center, Medical Director of the Vascular Diagnostic Laboratory, and
director of Care Redesign at the Massachusetts General Hospital. Dr. Jaff is an active
clinical consultant in all aspects of vascular medicine and has published extensively
in the field of Vascular Medicine with over 160 peer-reviewed publications and 9
textbooks. He is a Past-President and Master of the Society for Vascular Medicine. He is the founder and
Medical Director of the Vascular Ultrasound Core Laboratory, participating in over 160 trials in 60
countries around the World. Dr. Jaff competed the general management program at Harvard Business
School and is the first incumbent Paul and Phyllis Fireman Endowed Chair in Vascular Medicine at
Massachusetts General Hospital.
James D. Joye, DO Interventional Cardiology
Dr. James Joye is a founding board member of VIVA Physicians. He serves as Chief
Medical Officer of the Fogarty Institute for Innovation and as Director of TAVR at
the Heart & Vascular Institute at El Camino Hospital in Mountain View, CA. Dr. Joye
has authored over 20 patents and is credited with the development of cryoplasty
and percutaneous femoropopliteal bypass.
John A. Kaufman, MD Interventional Radiology
Dr. John Kaufman is the Fredrick S. Keller Professor of Interventional Radiology and the Director of the
Dotter Interventional Institute at Oregon Health & Science University. He also has appointments in
Vascular Surgery and Cardiology. Dr. Kaufman's primary clinical interests are aortic disease, venous
diseases, and vascular malformations. His clinical research has focused on IVC filters.
John R. Laird Jr., MD Interventional Cardiology
John R. Laird, is Professor of Medicine and Medical Director of the Vascular Center
at the University of California, Davis, Medical Center. He is an Interventional
Cardiologist who has been performing peripheral vascular interventions for over 20
years. Dr. Laird has served as Principal Investigator for numerous multicenter
clinical trials of new devices for vascular intervention.
Sean P. Lyden, MD Vascular Surgery
Sean Lyden, MD, is an Associate Professor and vascular surgeon in the Department
of Vascular Surgery, Sydell and Arnold Miller Family Heart & Vascular Institute at
Cleveland Clinic, as well as the Medical Director of Clinical Supply Chain
Management for the Cleveland Clinic Health System.
Manish Mehta, MD Vascular Surgery
Dr. Manish Mehta is the Professor of Surgery and Endowed Chair for Vascular
Education at Albany Medical College. He is also the President /CEO for the Center
for Vascular Awareness and Founder and Director of Albany Vascular International
Academy. He is a frequent presenter at National and International meetings as well
as a principal investigator for clinical trials. Additionally, Dr. Mehta has authored
peer-reviewed publications, serves on editorial boards and received the President’s
Award for Vision, VDF, for dedication to vascular health awareness.
D. Christopher Metzger, MD Interventional Cardiology
Dr. D. Christopher Metzger, MD is an interventional cardiologist in a 40-person
cardiology group at Wellmont Holston Valley Medical Center in Kingsport,
Tennessee. He is a high-volume operator with >4000 endovascular & >1700
carotid stent interventions. He participates as PL and has been lead enroller in
many CAS and PV trials, and has served as faculty at many major scientific
meetings. His professional passions are clinical research, endovascular
intervention, and teaching.
Krishna Rocha-Singh, MD Interventional Cardiology
Dr. Krishna Rocha-Singh received his undergraduate medical education at UCLA and general internal
medicine training at the Univ. of Colorado. He completed a basic science research fellowship in the
Dept. of Clinical Pharmacology and Experimental Therapeutics at the Cardiovascular Research Institute
at the Univ. of California, San Francisco (UCSF) with an interest in cellular mechanisms and
transmembrane signaling of cardiac proteins. He completed his general cardiology fellowship at UCSF
and trained in coronary and peripheral interventions at the Scripps Clinic and Research Foundation. He
joined Prairie Cardiovascular Consultants, Ltd., in 1993 and has served in leadership positions within the
ACC and ABVM. He serves on editorial boards of academic journals and has authored over 100 peerreviewed manuscripts, book chapters and abstracts on endovascular and interventional subjects. He is a
National Principal Investigator for clinical device trials and is a founding board member of VIVA.
Kenneth Rosenfield, MD Interventional Cardiology
Dr. Kenneth Rosenfield has been a leader, innovator, and educator in vascular
medicine and cardiology for two decades. He has served as National PI of several
seminal clinical trials and occupies leadership roles in industry-sponsored trials. He
has served on numerous committees for ACC, AHA, and SCAI and has recently
developed a national carotid stenting database, aimed at improving quality and
reducing errors.
John H. Rundback, MD Interventional Radiology
Dr. John Rundback has been the Director of the Interventional Institute at Holy
Name Medical Center since the Fall of 2005 and the Founder and Managing Partner
of Advanced Interventional Radiology Services, LLP (AIRS). He is a graduate of SUNY
Downstate Medical Center, did his residency at Beth Israel Medical Center in NYC,
and fellowship at Washington Hospital Center in Washington, D.C.
Peter Schneider, MD Vascular Surgery
Dr. Schneider is Chief of Vascular at Kaiser Foundation Hospital in Honolulu and a
full-time vascular surgeon. He is a graduate of Johns Hopkins University School of
Medicine and did residency and vascular surgery fellowship at University of
California, San Francisco. He has a long term interest in teaching and developing
endovascular techniques.
VIVA Social Media Channels

Facebook https://www.facebook.com/vivaphysicians




Twitter (@vivaphysicians) https://twitter.com/vivaphysicians
LinkedIn http://www.linkedin.com/groups/VIVA-Physicians-3931120
Website www.vivaphysicians.org
VIVA Logos